NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction

Journal of Cardiovascular Medicine

Volumn 11, Issue 5, 2010, Pages 359-364

  Rossetti, Enrico ^a   Mariani, Matteo ^a   Poli, Arnaldo ^a   Palmerini, Tullio ^b   Finazzi, Sergio ^c   Lotzniker, Milvia ^c   Sangiorgi, Diego ^b   De Servi, Stefano ^a  

^a Ospedale Civile di Legnano   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ospedale di Legnano   (Italy)

Author keywords

Acute myocardial infarction; Myocardial blush; NT pro BNP

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; REPERFUSION; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STROKE VOLUME;

EID: 77950274236     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283366834     Document Type: Article

References (21)

1. Van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, De Boer M, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998; 97:2302-2306.
2. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101:125-130.
3. Henriques JP, Zijlstra F, Van 't Hof AW, De Boer MJ, Dambrink JH, Gosselink M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003; 107:2115-2119.
4. Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004; 44:305-312.
5. Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ruźyllo W, O'Neill WW, et al., for the APEX-AMI Investigators. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study. Eur Heart J 2008; 29:1127-1135.
6. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90:195-203.
7. Stein BC, Levin RI. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998; 135:914-923.
8. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. New Engl J Med 2001; 345:1014-1021.
9. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107:2786-2792.
10. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88:82-91.
11. Talwar S, Squire IB, Downie PF, McCullough AM, Campton MC, Davies JE, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J 2000; 21:1514-1521.
12. Brodie BR, Hansen C, Stuckey TD, Richter S, Versteeg DS, Gupta N, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 2006; 47:289-295.
13. McNamara RL, Wang J, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al., for the NRMI Investigators. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006; 47:2180-2186.
14. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44:1988-1995.
15. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 2004; 110:1387-1391.
16. Svilaas T, Vlaar PJ, Van Der Horst IC, Diercks GF, De Smet BJ, Van Den Heuvel AF, et al. Thrombus aspiration during primary percutaneous coronary intervention. New Engl J Med 2008; 358:557-567.
17. Poli A, Fetiveau F, Vandoni P, del Rosso G, D'Urbano M, Seveso G, et al. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002; 106:313-318.
18. Kuklinska AM, Sobkowicz B, Kaminski KA, Mroczko B, Musial WJ, Szmitkowski M, et al. The benefits of repeated measurements of B-type natriuretic peptide in patients with first ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Int Heart J 2006; 47:843-854.
19. Sinnaeve PR, Erekowitz JA, Bogaerts K, Droogne W, Jarai R, Huber K, et al. ASSENT-4 PCI Investigators. Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pretreatment with full-dose fibrinolysis. Eur Heart J 2009; 30:2213-2219.
20. Mega JL, Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004; 44:335-339.
21. Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 2008; 117:1936-1944.